CTLA-4 polymorphism in Iranian patients with systemic lupus erythematosus

Mahdieh Shojaa, Mahsa Amoli, Mehrdad Aghaie, Patricica Khashayar, Naemeh Javid, Fatemeh Shakeri, Abbas Ali Keshtkar, Mostafa Qorbani, Ramin Mohebi


Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) is an important negative regulator of T-cell responses. CTLA-4 polymorphisms have been confirmed to be associated with several autoimmune diseases such as systemic lupus erythematosus (SLE). We analyzed the role of +49AG polymorphism in exon1 of the CTLA-4 gene in Iranian patients suffering from SLE. A cohort of 180 SLE patients and 304 ethnically and age matched healthy controls were studied. Polymerase chain reaction restriction fragments length polymorphism (PCR-RFLP) was used to analyze the genotype and allele frequencies of these polymorphisms. We found that the AA genotype was significantly higher in SLE patients (67.2% vs. 41.1%, p=0.0001). The AG genotype frequency, on the other hand, was more frequently reported in the controls (49.7% vs. 27.8%, p=0.0001). The GG genotype was also more common in the control group than SLE patients but the difference was not significant (p=0.06). The frequency of G allele was significantly higher in SLE patients: 34% versus 18.9% than in control (p=0.0001). There was no significant correlation between the risk of developing SLE and the individual’s age, parental consanguinity, and family history of SLE. We didn’t observe any significant association between genotype and the clinical features of SLE. We conclude that the +49AG polymorphism of CTLA-4 gene appear to play a significant role in the development SLE in the Iranian patients, but not to be associated with clinical features of SLE.


Medicine; Genetics; Systemic lupus erythematosus; CTLA-4; exon1; 49AG polymorphism

Full Text:



Walunas TL, Bakker CY, Bluestone JA, CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 183:2541-2550, 1996.

Utz PJ. Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus. Lupus 13: 304-311, 2004.

Marshall E. Lupus: mysterious disease holds its secrets tight. Science 296:689-691, 2002.

Stahl-Hallengren C, Jonsen A, Nived O, Sturfelt G. Incidence studies of systemic lupus erythematosus in southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 27:685-691, 2000.

Davatchi F, Jamshidi AR, Banihashemi AT, Gholami J, Forouzanfar MH, Akhlaghi M, et al. WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran. J Rheumatol 35:1384, 2008.

Kyogoku C, Tsuchiya N. A compass that points to lupus: genetic studies on type I interferon pathway. Genes Immun 8:445-455, 2007.

Lee JH, Wang LC, Lin YT, Yang YH, Lin DT, Chiang BL. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 117:280, 2006.

Wakeland EK, Liu K, Graham RR, Behrens TW. Delineating the genetic basis of systemic lupus erythematosus. Immnunity 15:397, 2001.

Ariyan C, Salvalaggio P, Fecteau S, Deng S, Rogozinski L, Mandelbrot D, et al. Cutting edge: transplantation tolerance through enhanced CTLA- 4 expression. J Immunol 171:5673-5677, 2003.

Harper, K., Balzano, C., Rouvier, E., Mattéi, M.G., Luciani, M.F. & Golstein, P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. Open J Immunol

:1037, 1991.

Kristiansen OP, Larsen ZM, Pociot F: CTLA-4 in autoimmune diseases–a general susceptibility gene to auto-immunity?. Genes Immun 1:170-184, 2000.

Hochberg M. C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheumatol 40:1725, 1997.

Fernandez-Blanco L, Perez-Pampin E, Gomez-Reino J. J, Gonzalez A, “A CTLA-4 polymorphism associated with susceptibility to systemic lupus erythematosus,” Arthritis Rheumatol 50:328-329, 2004

Lee YH, Choi SJ, Kim YR, Ji JD, Song GG, PM G, et al. Polymorphisms of CTLA-4 Exon 1 and Promoter Genes in Systemic Lupus Erythematosus and Rheumatoid Arthritis. J Korean Rheum Assoc 7:53-61, 2000.

Ulker M, YazisizV, Sallakci N, Avci A. B, Sanlio-glu S, Yegin O, Terzioglu E . CTLA-4 gene polymer-phism of exon 1( + 49 A/G) in Turkish systemic lupus erythematosus patients. J Immunogenet 36: 245-250, 2009.

An-ping XU, Pei-da YIN, Xiao-yan SU. Association of CTLA4 promoter -1722TC with systemic lupus erythematosus in Chinese. J fris mil med univ 24:1107-1112, 2004.

Takeuchi F, Kawasugi K, Nabeta H, Mori M, Tanimoto K.CTLA-4 dimorphisms in Japanese patients with systemic lupus erythematosus. Clin Exp Rheumato l21:527-528, 2002.

Parks CG, Hudson LL, Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Pandey JP. CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States. J

Lupus 13:784-791, 2004.

Chua KH, Puah SM, Chew CH, Tan SN, Lian LH. Study of the CTLA-4 gene polymorphisms in systemic lupus erythematosus (SLE) samples from Malaysia, Ann.

Hum. Biol 37: 274-280, 2010.

Aguilar F, Torres B, Sanchez-Roman J, Nunez-Roldan A, Gonzalez-Escribano MF. CTLA4 polymor-phism in Spanish patients with systemic lupus erythe-matosus. Hum Immunol 64:936-940, 2003.

Pullmann R Jr, Lukac J, Skerenova M, Rovensky J, Hybenova J, Melus V, Celec S, Pullmann R, Hyrdel R. Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus. Clin Exp Rheumatol 17:725-729, 1999.

Ahmed. S, Ihara. K, Kanemitsu .S, Nakashima.H, Otsuka.T, Tsuzaka.K, Takeuchi. T and Hara. T, Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. J Rheumatol 40: 662-667, 2001.

Barreto M, Santos E, Ferreira R, Fesel C, Fontes MF, Pereira C,Martins B, Andreia R, Viana JF, Crespo F, Vasconcelos C, Ferreira C, Vicente AM ,Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur J Hum Genet 12:620-626, 2004.

Liu MF, Wang CR, Lin LC, Wu CR , CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus. Lupus 10:647-649, 2001.

Kimkong I, Nakkuntod J, Sae-Ngow S, SnabboonT, Avihingsanon Y, Hirankarn N, Association between CTLA-4 polymorphisms and the susceptibility to systemic lupus erythematosus and Graves’disease in Thai population. APJAI 29:229-235, 2011.

Matsushita M, Tsuchiya N, Shiota M, Komata T, Matsuta K, Zama K, Oka T, Juji T, Yamane A, Tokunaga K. Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method. Tissue Antigens 54:578-584, 1999.


  • There are currently no refbacks.